ShangPharma opens Fengxian facility
ShangPharma has opened a multi-purpose pharmaceutical development cGMP manufacturing facility in Fengxian, China, and started operations on the initial phase of production.
ShangPharma has opened a multi-purpose pharmaceutical development cGMP manufacturing facility in Fengxian, China, and started operations on the initial phase of production.
GSK has set aside an additional £2.2bn ($3.4bn) to cover anticipated Q4 legal costs related to a US investigation of its diabetes drug Avandia.
Italy-based API maker Euticals will buy fine chemicals firm Archimica from investment group TowerBrook Capital Partners.
Ecron Acunova has expanded its Mangalore, India, clinical pharmacology unit to house 80 beds as demand rises from US and Canadian clients for pharmacokinetic and pharmacodynamic (PK/PD) studies.
US CRO INC Research has bought industry consulting group Avos Life Sciences, citing pharma clients’ need to maximize return on R&D and minimize risk as the key driver.
The UK NHS will award a prize to innovations that increase patient compliance and, as a result, help it make better use of resources.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Norwich Pharmaceuticals and Prism Ideas.